article_metadata: Wina S Utama Wahyu Lestari Sitti Hajar Mahriani Sylvawani Fitri D Ismida Richard Y Akele
article_metadata: 10.52225/narra.v4i1.207
article_metadata: Narra J
article_metadata: 2024 Apr;4(1):e207.
article_metadata: il-17 inhibitor psoriasis vulgaris biologic agent psoriatic arthritis secukinumab
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38798877/
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Arthritis, Psoriatic / drug therapy Interleukin-17 / antagonists & inhibitors Psoriasis / drug therapy
article_metadata: Antibodies, Monoclonal, Humanized / administration & dosage Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Arthritis, Psoriatic / drug therapy Interleukin-17 / antagonists & inhibitors Psoriasis / drug therapy Case Reports Adult Female Humans secukinumab Antibodies, Monoclonal, Humanized Interleukin-17 IL17A protein, human
article_metadata: PMC11125376
article_metadata: 38798877
article_metadata: Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects
article_metadata: 2024